![Basilea Pharmaceutica AG logo](/logos/BSLN.SW.webp)
Basilea Pharmaceutica AG
SIX:BSLN.SW
Overview | Financials
Company Name | Basilea Pharmaceutica AG |
Symbol | BSLN.SW |
Currency | CHF |
Price | 45.25 |
Market Cap | 548,478,237 |
Dividend Yield | 0% |
52-week-range | 32 - 48.55 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. David Veitch |
Website | https://www.basilea.com |
An error occurred while fetching data.
About Basilea Pharmaceutica AG
Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. It offers Cresemba, an intravenous and oral azole antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD